Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Locally Advanced Pancreatic Cancer
a study on Pancreatic Cancer
Pancreatic Cancer Non-resectable locally advanced pancreatic cancer unresectable pancreatic cancer Pancreatic Neoplasms Leucovorin Gemcitabine Paclitaxel Albumin-Bound Paclitaxel Irinotecan Fluorouracil Folfirinox Levoleucovorin Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Lead Scientist at UCSD
- Tony Reid, MD
Professor Tony Reid’s main career goals are to develop novel therapeutic approaches to diagnose, prevent, and treat tumors with gene therapy vectors. He has focused on elucidating the underlying molecular mechanism that causes cancer, focusing primarily in gastrointestinal tumors including colorectal, pancreatic, esophageal and hepatobillary cancers.